127 related articles for article (PubMed ID: 16931017)
1. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma.
Fernandez-Aguilar S; Jondet M; Simonart T; Nöel JC
Breast; 2006 Dec; 15(6):782-5. PubMed ID: 16931017
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
Gong Y; Sun X; Huo L; Wiley EL; Rao MS
Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
[TBL] [Abstract][Full Text] [Related]
4. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
5. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
9. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
[TBL] [Abstract][Full Text] [Related]
10. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.
Fernandez-Aguilar S; Noël JC
APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
Raica M; Cimpean AM; Ceausu R; Ribatti D
Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
[TBL] [Abstract][Full Text] [Related]
12. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
[TBL] [Abstract][Full Text] [Related]
15. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
[TBL] [Abstract][Full Text] [Related]
16. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.
Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K
Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987
[TBL] [Abstract][Full Text] [Related]
17. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
18. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].
Zhen LF; Ye CS; Liu MF; Ding GP; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1548-51. PubMed ID: 20650763
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
